Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Eleva Biologics is a clinical-stage biopharmaceutical company pioneering the development of biologics using a proprietary moss-based expression platform. Our innovative pipeline includes therapies for unmet medical needs, such as Factor H for C3 Glomerulopathy (C3G) and a novel treatment for Fabry disease, currently in Phase 1/2 trials. By leveraging our advanced manufacturing technology, we aim to produce complex biologics ef...
Eleva Biologics is a clinical-stage biopharmaceutical company pioneering the development of biologics using a proprietary moss-based expression platform. Our innovative pipeline includes therapies for unmet medical needs, such as Factor H for C3 Glomerulopathy (C3G) and a novel treatment for Fabry disease, currently in Phase 1/2 trials. By leveraging our advanced manufacturing technology, we aim to produce complex biologics efficiently, delivering transformative therapies to improve patient outcomes worldwide.

List your booth number for exhibitions, ask us